194 related articles for article (PubMed ID: 15129186)
1. Sustained blockade of brain AT1 receptors before and after focal cerebral ischemia alleviates neurologic deficits and reduces neuronal injury, apoptosis, and inflammatory responses in the rat.
Lou M; Blume A; Zhao Y; Gohlke P; Deuschl G; Herdegen T; Culman J
J Cereb Blood Flow Metab; 2004 May; 24(5):536-47. PubMed ID: 15129186
[TBL] [Abstract][Full Text] [Related]
2. [Effect of irbesartan on focal cerebral ischemia in rats].
Lou M; Ding MP; Wen SQ; Xia Q
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2006 May; 22(2):190-4. PubMed ID: 21162238
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of neuroprotective effect of single and combined blockade of AT1 receptor and PARP-1 in focal cerebral ischaemia in rat.
Singh N; Sharma G; Singh N; Hanif K
Int J Stroke; 2014 Jul; 9(5):560-8. PubMed ID: 23013350
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?
Culman J; Jacob T; Schuster SO; Brolund-Spaether K; Brolund L; Cascorbi I; Zhao Y; Gohlke P
Naunyn Schmiedebergs Arch Pharmacol; 2017 Sep; 390(9):949-959. PubMed ID: 28669009
[TBL] [Abstract][Full Text] [Related]
5. Blockade of central angiotensin AT(1) receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats.
Dai WJ; Funk A; Herdegen T; Unger T; Culman J
Stroke; 1999 Nov; 30(11):2391-8; discussion 2398-9. PubMed ID: 10548676
[TBL] [Abstract][Full Text] [Related]
6. Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial.
Culman J; Nguyen-Ngoc M; Glatz T; Gohlke P; Herdegen T; Zhao Y
Exp Neurol; 2012 Dec; 238(2):243-53. PubMed ID: 22995601
[TBL] [Abstract][Full Text] [Related]
7. Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death.
Xu J; Culman J; Blume A; Brecht S; Gohlke P
Stroke; 2003 May; 34(5):1287-92. PubMed ID: 12677021
[TBL] [Abstract][Full Text] [Related]
8. [Irbesartan reduces inflammatory response of central nervous system in a rat model of fluid percussion brain injury].
Xing G; Wei M; Xiu B; Ma Y; Liu T
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jul; 32(7):917-20. PubMed ID: 27363272
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II AT1 receptor blockade reverses pathological hypertrophy and inflammation in brain microvessels of spontaneously hypertensive rats.
Ando H; Zhou J; Macova M; Imboden H; Saavedra JM
Stroke; 2004 Jul; 35(7):1726-31. PubMed ID: 15143297
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury.
Li J; Culman J; Hörtnagl H; Zhao Y; Gerova N; Timm M; Blume A; Zimmermann M; Seidel K; Dirnagl U; Unger T
FASEB J; 2005 Apr; 19(6):617-9. PubMed ID: 15665034
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective Effect of Scutellarin on Ischemic Cerebral Injury by Down-Regulating the Expression of Angiotensin-Converting Enzyme and AT1 Receptor.
Wang W; Ma X; Han J; Zhou M; Ren H; Pan Q; Zheng C; Zheng Q
PLoS One; 2016; 11(1):e0146197. PubMed ID: 26730961
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin gallate alleviates neuronal cell damage against focal cerebral ischemia in rats.
Park DJ; Kang JB; Koh PO
J Vet Med Sci; 2020 May; 82(5):639-645. PubMed ID: 32224555
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of irbesartan, an angiotensin II receptor antagonist, alone and in combination with aspirin on middle cerebral artery occlusion model of focal cerebral ischemia in rats.
Pratap R; Pillai KK; Khanam R; Islam F; Ahmad SJ; Akhtar M
Hum Exp Toxicol; 2011 May; 30(5):354-62. PubMed ID: 20488839
[TBL] [Abstract][Full Text] [Related]
14. Cerebral ischemia enhances vascular angiotensin AT1 receptor-mediated contraction in rats.
Stenman E; Edvinsson L
Stroke; 2004 Apr; 35(4):970-4. PubMed ID: 15001791
[TBL] [Abstract][Full Text] [Related]
15. Chelating intracellularly accumulated zinc decreased ischemic brain injury through reducing neuronal apoptotic death.
Zhao Y; Pan R; Li S; Luo Y; Yan F; Yin J; Qi Z; Yan Y; Ji X; Liu KJ
Stroke; 2014 Apr; 45(4):1139-47. PubMed ID: 24643405
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of 4-amino-1,8-napthalimide, a poly(ADP ribose) polymerase inhibitor in middle cerebral artery occlusion-induced focal cerebral ischemia in rat.
Kabra DG; Thiyagarajan M; Kaul CL; Sharma SS
Brain Res Bull; 2004 Feb; 62(5):425-33. PubMed ID: 15168908
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of olprinone after cerebral ischemia/reperfusion injury in rats.
Genovese T; Mazzon E; Paterniti I; Esposito E; Cuzzocrea S
Neurosci Lett; 2011 Oct; 503(2):93-9. PubMed ID: 21872644
[TBL] [Abstract][Full Text] [Related]
18. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
[TBL] [Abstract][Full Text] [Related]
19. Cerebral ischemia induced inflammatory response and altered glutaminergic function mediated through brain AT
Justin A; Divakar S; Ramanathan M
Biomed Pharmacother; 2018 Jun; 102():947-958. PubMed ID: 29710550
[TBL] [Abstract][Full Text] [Related]
20. Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke.
Brdon J; Kaiser S; Hagemann F; Zhao Y; Culman J; Gohlke P
J Hypertens; 2007 Jan; 25(1):187-96. PubMed ID: 17143191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
